FIVE PRIME THERAPEUTICS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 31224
 
  
 
C07K PEPTIDES 31105
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 841
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 8159
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 594
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5201
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0016,555 SLAMF1 ANTAGONISTS AND USES THEREOFOct 21, 15Jan 18, 18[C12N, G01N, C07K]
2018/0002,399 FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIESJun 23, 17Jan 04, 18[A61K, C07K]
2017/0349,643 COMPOSITIONS AND METHODS OF TREATING DISEASE WITH FGFR FUSION PROTEINSJun 12, 17Dec 07, 17[A61K, C07K]
2017/0145,102 FGFR2 INHIBITORS ALONE OR IN COMBINATION WITH IMMUNE STIMULATING AGENTS IN CANCER TREATMENTNov 22, 16May 25, 17[C07K]
2017/0145,103 PREDICTING RESPONSE TO CANCER TREATMENT WITH FGFR2 INHIBITORSNov 22, 16May 25, 17[A61K, G01N, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9775881 Methods of treating mesothelioma by administration of compounds comprising FGFR1 ECDMay 22, 14Oct 03, 17[A61K, C12Q, G01N, C07K]
9765147 Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancerOct 28, 15Sep 19, 17[A61K, C07K]
9695243 Antibodies that bind colony stimulating factor 1 receptor (CSF1R)Oct 27, 15Jul 04, 17[A61K, C12N, C07K]
9475871 Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteinsNov 24, 14Oct 25, 16[C07K]
9200075 Nucleic acids encoding antibodies that bind colony stimulating factor 1 receptor (CSF1R)Apr 30, 14Dec 01, 15[C12N, C07K]
9192683 Methods of treating disease with FGFR1 fusion proteinsOct 08, 13Nov 24, 15[A61K, C07K]
9173957 FGFR2 fusion proteins comprising C-terminal deletion mutants of FGFR2-IIICMay 29, 13Nov 03, 15[A61K, C07K]
9175065 FGFR extracellular domain acidic region muteinsSep 12, 12Nov 03, 15[A61K, A61P, C07K]
9169313 Method of treatment of cancers characterized by ligand-dependent activating mutations in FGFR2 with FGFR1 ECD proteinsNov 14, 13Oct 27, 15[A61K, C07K]
8951972 FGFR1 extracellular domain combination therapies for lung cancerNov 14, 11Feb 10, 15[A61K, C12P, A61P, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0017,024 FAM150A, FAM150B, AND FAM150 ANTAGONISTS AND USES THEREOFAbandonedMar 07, 14Jan 21, 16[A61K, G01N, C07K]
2015/0050,273 AFUCOSYLATED ANTI-FGFR2IIIB ANTIBODIESAbandonedJul 31, 14Feb 19, 15[C07K]
2014/0274,898 HAIR GROWTH METHODS USING FGFR3 EXTRACELLULAR DOMAINSAbandonedFeb 20, 14Sep 18, 14[A61K, C07K]
2014/0170,145 COMPOSITIONS AND METHODS OF USE FOR MGD-CSF IN DISEASE TREATMENTAbandonedOct 08, 13Jun 19, 14[C07K]
2014/0086,840 Therapeutic Antibody Target Validation and Screening In VivoAbandonedSep 06, 13Mar 27, 14[A61K]
2014/0079,699 METHODS OF TREATING CONDITIONS WITH ANTIBODIES THAT BIND COLONY STIMULATING FACTOR 1 RECEPTOR (CSF1R)AbandonedAug 30, 13Mar 20, 14[A61K, C07K]
2013/0302,322 METHODS OF TREATING CONDITIONS WITH ANTIBODIES THAT BIND COLONY STIMULATING FACTOR 1 RECEPTOR (CSF1R)AbandonedMay 10, 13Nov 14, 13[A61K, C07K]
2013/0189,262 IL-27 Antagonists for Treating Inflammatory DiseasesAbandonedMar 15, 13Jul 25, 13[A61K]
2013/0136,740 METHODS OF TREATING CANCERAbandonedNov 13, 12May 30, 13[A61K]
2012/0183,477 Therapeutic Antibody Target Validation and Screening In VivoAbandonedJun 25, 10Jul 19, 12[A61K]
2012/0183,548 IL-27 Antagonists for Treating Inflammatory DiseasesAbandonedJan 13, 12Jul 19, 12[A61K, C12N, A61P]
2011/0319,324 METHODS OF AND COMPOSITIONS FOR STIMULATION OF GLUCOSE UPTAKE INTO MUSCLE CELLS AND TREATMENT OF DISEASESAbandonedNov 29, 10Dec 29, 11[A61K, A61P]
2010/0210,829 Compositions and Methods for Treating Diseases, Disorders, or Conditions Characterized by Myelin Degeneration, Myelin Deficiency or LossAbandonedMar 07, 08Aug 19, 10[C07H]
2010/0183,620 COMPOSITIONS AND METHODS FOR REGULATING COLLAGEN AND SMOOTH MUSCLE ACTIN EXPRESSION BY SERPINE2AbandonedNov 25, 09Jul 22, 10[A61K, C12Q, A61P]
2010/0015,047 Lung-Expressed PolypeptidesAbandonedAug 31, 09Jan 21, 10[A61K]
2009/0286,954 Human cDNA Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their UseAbandonedApr 15, 09Nov 19, 09[C07K]
2009/0214,517 Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating diseaseAbandonedJul 27, 05Aug 27, 09[A61K, A61P]
2008/0286,834 Leader Sequences For Directing Secretion of Polypeptides and Methods For Production ThereofAbandonedJan 27, 06Nov 20, 08[C12P, C12N, C07K]
2008/0254,033 Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of DiseasesAbandonedJan 21, 05Oct 16, 08[A61K, C12N, A61P, C07K]
2008/0242,603 Novel Apo2L and IL-24 Polypeptides, Polynucleotides, and Methods of Their UseAbandonedFeb 18, 05Oct 02, 08[A61K, C07H, C12N, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.